Hopp til hovedinnhold

Somatoforme lidelser

Sist oppdatert: Sist revidert:
Sist revidert av:

Definisjon:
Gjentatte presentasjoner av vedvarende og subjektivt forstyrrende somatiske symptomer til tross for gjentatte negative funn og forsikringer fra legen om at symptomene ikke har noe somatisk grunnlag
Forekomst:
Tilstanden er overrepresentert i helsetjenesten, men mindre vanlig i et befolkningsperspektiv
Symptomer:
Kan henføres til hvilket som helst organsystem eller kombinasjon av slike. Et betydelig antall symptomer kan foreligge
Funn:
Normale kliniske funn
Diagnostikk:
Ingen prøver er av diagnostisk betydning annet enn differensialdiagnostisk
Behandling:
Innebærer å formidle en plausibel forklaringsmodell for kroppsymptomer uten påvist organisk sykdom, og å forklare pasientens plager i denne modellen. Ellers samtaleterapi og kognitiv behandling
  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
  2. Kurlansik SL, Maffei MS. Somatic symptom disorder. Am Fam Physician. 2016 Jan 1;93(1):49-54A.
  3. Oyama O, Paltoo C, Greengold J. Somatoform disorders. Am Fam Physician 2007; 76: 1333-8. PubMed  
  4. Rosendal M, Blankenstein AH, Morriss R, Fink P, Sharpe M, Burton C. Enhanced care by generalists for functional somatic symptoms and disorders in primary care. Cochrane Database Syst Rev. 2013;10:CD008142. Cochrane (DOI)  
  5. Nimnuan C, Rabe-Hesketh S, Wessely S et al. How many functional somatic syndromes? J Psychosom Res 2001; 51: 549-57. PubMed  
  6. Croicu C, Chwastiak L, Katon W. Approach to the patient with multiple somatic symptoms. Med Clin North Am. 2014;98(5):1079–1095.
  7. Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011;52(3):263–271.
  8. Hatcher S, Arroll B. Assessment and management of medically unexplained symptoms. BMJ. 2008;336(7653):1124–1128.
  9. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004; 184: 470-6. British Journal of Psychiatry  
  10. Fink P, Hansen MS, Oxhøj ML. The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 2004.
  11. Fink P, Hansen MS, Sondergaard L et al. Mental illness in new neurological patients. J Neurol Neurosurg Psychiatry 2003; 74: 817-9. PubMed  
  12. Harris AM, Orav EJ, Bates DW, Barsky AJ. Somatization increases disability independent of comorbidity. J Gen Intern Med. 2009;24(2):155–161.
  13. Stenager EN et al. Førtidspension til patienter med syndromsygdomme. Ugeskr Læger 2004; 165: 469-74. Ugeskrift for Læger  
  14. Rief W, Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev 2008; 27: 821-41. PubMed  
  15. Witthöft M, Hiller W. Psychological approaches to origins and treatments of somatoform disorders. Ann Rev Clin Psychol 2010; 6: 257-83. PubMed  
  16. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007; 369: 946-55. PubMed  
  17. Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet. 2014;383(9913):219–225.
  18. Birket-Smith M. Somatization and chronic pain. Acta Anaesthesiol Scand 2001; 45: 1114-20. PubMed  
  19. van Dessel N, den Boeft M, van der Wouden JC, et al. Non‐pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews 2014, Issue 11. Art. No.: CD011142. The Cochrane Library  
  20. Cooper K, Gregory JD, Walker I, et al. Cognitive Behaviour Therapy for Health Anxiety: A Systematic Review and Meta-Analysis. Behav Cogn Psychother. 2017 Mar;45(2):110-123 . pmid:28229805 PubMed  
  21. Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database of Systematic Reviews 2014, Issue 11. Art. No.: CD010628. Cochrane (DOI)  
  22. Yates WR. Somatic Symptom Disorders Medication. Medscape, last updated Apr 23, 2019. emedicine.medscape.com  
  23. Stonnington C, Driver-Dunckley E, Noe KH, Locke D. Conversion and somatic symptom disorders. BMJ Best Practice, last reviewed November 2019.
  24. Peveler R. Understanding medically unexplained physical symptoms: faster progress in the next century than in this? J Psychosom Res 1998; 45: 93-7. PubMed  
  25. olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van Weel C. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res. 2009 May;66(5):363-77. doi: 10.1016/j.jpsychores.2008.09.018. Epub 2008 Dec 16. PMID: 19379952. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim
  • Dr. Stephan Schüler, avdelingsoverlege Nevrologisk avdeling, Sykehuset Namsos

Tidligere fagmedarbeidere

  • Olav M. Linaker, førsteamanuensis, spesialist i psykiatri, Psykiatrisk Institutt, Norges teknisk-naturvitenskapelige universitet, Trondheim
  • Olav Thorsen, spesialist allmennmedisin, Klubbgaten legesenter, Stavanger